Introduction
============

Glaucomas are a heterogeneous group of eye conditions with manifestation as early as birth to very late age of onset and are among most common cause of blindness worldwide, accounting for 15% of cases. Primary congenital glaucoma (PCG; OMIM [231300](http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=231300); provided in the public domain by the National Centre for Biotechnology Information, Bethesda, MD) is a severe form of glaucoma with manifestation at birth or early childhood. It is characterized by elevated intra-ocular pressure (IOP), and enlarged cornea and globe (buphthalmos) \[[@r1]\]. The only observable anatomic defect in PCG is trabecular-dysgenesis. This leads to impaired aqueous drainage, increased intraocular pressure, optic nerve damage, and may consequently lead to partial/permanent visual impairment. Progressive degeneration of retinal ganglion cells (RGCs) and their axons is the primary cause of glaucomatous visual loss. However, many aspects of this blinding disorder are still unclear and current treatment options are not sufficient to block neurodegenerative injury in these patients.

PCG is bilateral in 80% cases. The majority of PCG cases present within the first year of life out of which 25% are diagnosed in the neonatal period and in about 60% within first six months of life. The majority of PCG cases are sporadic. PCG is the most common type of pediatric glaucoma and accounts for 55% of pediatric glaucomas. The prevalence of PCG varies across ethnic communities ranging from 1 in 10,000--20,000 in the western populations \[[@r2]\] to 1 in 2,500 and 1 in 1,250 in the Saudi Arabian population \[[@r3]\] and Gypsy population of Slovakia \[[@r2]\], and 1 in 3,300 in Andhra Pradesh, India \[[@r4]\]. Early and reliable diagnosis of this disease is vital, so that appropriate and prompt treatment is initiated. This can improve the visual outcome and prevent visual loss.

Three genetic loci: GLC3A at 2p21, GLC3B at 1p36, and GLC3C at 14q24.3-q31.1 have been mapped for PCG \[[@r3],[@r5],[@r6]\]. Mutations in *CYP1B1* (GLC3A locus) have been found in PCG patients from different populations \[[@r3],[@r7]-[@r10]\] It is estimated that all known loci/genes of glaucoma account for the minority of total cases of glaucoma, and thus, many other genes remain to be identified.

The role of mitochondrial DNA (mtDNA) mutations and oxidative stress (OS) has been reported in primary open angle glaucoma (POAG) \[[@r11],[@r12]\]. Recent studies reported an increased frequency of mtDNA sequence changes in primary open angle glaucoma (POAG), primary angle closure glaucoma (PACG), and pseudoexfoliation glaucoma (PEG) compared to controls \[[@r11],[@r13],[@r14]\]. Therefore this study was planned with the aim to screen PCG cases for mitochondrial DNA variations.

Methods
=======

Clinical examination and selection of cases
-------------------------------------------

Primary congenital glaucoma cases (n=35) presenting at the Dr. R. P. Centre for Ophthalmic Sciences (AIIMS, New Delhi, India), were enrolled for this study, after ethical approval of the Institutional Review Board (IRB00006862; All India Institute of Medical Sciences, New Delhi, India). The diagnosis involved clinical ocular and systemic examination. Inclusion criteria of the patients were: increased corneal diameter (\>12.0 mm), raised IOP (\>21 mmHg) with presence/absence of Haab's striae, and optic disc changes (where examination was possible). Symptoms of epiphora and photophobia were additional inclusion factors. The age of onset ranged from birth to 3 years. All patients with a history of blood transfusion, TORCH ([Toxoplasmosis](http://www.fpnotebook.com/ID/Parasite/TxplsmGnd.htm); Rubella; Cytomegalovirus; Herpes Simplex Virus) infection, and drug intake in the mother during pregnancy were excluded. Glaucoma cases other than PCG were also excluded. Detailed family history of ocular or other hereditary disorders up to three generations were taken, and pedigree charts were constructed. Forty ethnically matched normal individuals without any ocular disorders with IOP\<20mmHg and corneal diameter \<12×12mm were enrolled as controls.

Sample collection and DNA isolation
-----------------------------------

Peripheral blood sample was collected from patients and controls by venipuncture after informed consent. Blood samples were collected in EDTA (EDTA) vaccutainers and stored in −80 °C (°C) until DNA isolation. DNA was isolated from whole blood using the phenol-chloroform method.

Polymerase chain reaction (PCR) amplification and sequence analysis of the mitochondrial DNA coding region
----------------------------------------------------------------------------------------------------------

The whole mitochondrial genome was amplified in all patients and controls using 24 pairs of primers \[[@r15]\]. PCR amplifications for all primer sets were performed in a 40 μl volume containing 1.0 μl of 20 μM stock solution for each primer, 100 ng of genomic DNA, 1 unit of Taq polymerase (Banglore Genei, Bengaluru, Karnataka, India), 0.1 mM of each dNTP, 4 μl of 10× PCR buffer (with 15 mM MgCl~2~), by means of 30 cycles of amplification, each consisting of 30 s denaturation at 94 °C, 30 s annealing at 56 °C and 1 min extension at 72 °C. Finally, and extension for 5 min at 72 °C was performed. Amplified PCR products were purified using a gel/PCR DNA fragments extraction kit (catalog number DF100; Geneaid Biotech Ltd., Sijhih City, Taiwan). Purified PCR products were sent for sequencing to MCLAB (Molecular Cloning Laboratories, South San Francisco, CA). The full mtDNA genome was sequenced except D-loop as D-loop is a hyper-variable region. All fragments were sequenced in both forward and reverse direction for confirmation. All sequence variants from both PCG patients and controls were compared to Human Mitochondrial reference sequence [NC_012920](http://www.ncbi.nlm.nih.gov/nuccore/NC_012920?log$=ACCN) provided by the National Center for Biotechnology Information ([NCBI](http://www.ncbi.nlm.nih.gov/)) using ClustalW2 (multiple sequence alignment program for DNA; European Molecular Biology Laboratory (EMBL) -- European Bioinformatics Institute (EBI).

Prediction of pathogenecity
---------------------------

For prediction of pathogenic characteristics of all non-synonymous mtDNA changes two homology based programs [PolyPhen](http://genetics.bwh.harvard.edu/pph) (Polymorphism Phenotyping) and [SIFT](http://sift.jcvi.org/) (Sorting Intolerant From Tolerant) analysis tool were used. [PolyPhen](http://genetics.bwh.harvard.edu/pph) structurally analyzes an amino acid polymorphism and predicts whether that amino acid change is likely to be deleterious to protein function \[[@r16]-[@r18]\]. The prediction is based on the position-specific independent counts (PSIC) score derived from multiple sequence alignments of observations in case of functional domain of protein and Predicted hydrophobic and transmembrane (PHAT) matrix element difference in case of transmembrane region of protein. [PolyPhen](http://genetics.bwh.harvard.edu/pph) scores of \>2.0 indicate the polymorphism is probably damaging to protein function. Scores of 1.5--2.0 are possibly damaging, and scores of \<1.5 are likely benign. [SIFT](http://sift.jcvi.org/) is a sequence homology-based tool that sorts intolerant from tolerant amino acid substitutions and predicts whether an amino acid substitution in a protein will have a phenotypic effect \[[@r19]-[@r22]\]. [SIFT](http://sift.jcvi.org/) is based on the premise that protein evolution is correlated with protein function. Positions important for function should be conserved in an alignment of the protein family, whereas unimportant positions should appear diverse in an alignment. Positions with normalized probabilities less than 0.05 are predicted to be deleterious and, those greater than or equal to 0.05 are predicted to be tolerated.

Statistical analysis
--------------------

Pearson χ^2^/Fisher's exact test was applied to make a comparison between two groups (cases versus controls). P-values less than 0.05 were considered as significant. All tests were done using SPSS software for windows (version 11.5; SPSS Inc., Chicago, IL).

Results
=======

MtDNA sequencing following whole genome amplification of mitochondrial DNA revealed a total of 132 nucleotide variations ([Table 1](#t1){ref-type="table"}) in PCG patients and 58 in controls ([Table 2](#t2){ref-type="table"}). Of the 132 nucleotide variations, 42 (31.81%) were non-synonymous, 82 (62.18%) were synonymous changes, and 8 were in RNA genes. In total, 23.48% (31/132) variations were novel out of which 41.93% (13/31) were non-synonymous ([Table 1](#t1){ref-type="table"}). A total of 66/132 (50.00%) variations were observed in complex I, 12/132 (9.09%) in complex III, 26/132 (19.69%) in complex IV, and 20/132 (15.15%) were in complex V ([Figure 1](#f1){ref-type="fig"}). Out of the total variations reported, complex I had 31.81% (21/66) non-synonymous base changes, complex III had 25.00% (3/12), complex IV had 23.07% (6/26), and complex V had 55.00% (11/20) non-synonymous base changes. Of 58 variations in the controls, 14 were non-synonymous changes.

###### Mitochondrial DNA variations observed in primary congenital glaucoma patients.

  **Sample number**   **Genomic Position**   **Base Change**   **Gene /Location**   **Amino acid position**   **Codon change**   **Amino acid change**   **Change in protein**   **Syn/ Non-syn**   **Total number of patients with nt changes**   **GenBank accession number if novel**
  ------------------- ---------------------- ----------------- -------------------- ------------------------- ------------------ ----------------------- ----------------------- ------------------ ---------------------------------------------- -----------------------------------------------------------------------------------
  1                   2707                   G\>A              *16s RNA*            \-                        \-                 \-                      \-                      \-                 1                                              \-
  2                   2790                   Ins T             *16s RNA*            \-                        \-                 \-                      \-                      \-                 2                                              [GU186097](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186097)
  3                   3311                   C\>T              *ND1*                2                         CCC\>CTC           Pro\>Leu                p.P2L                   non-syn            1                                              [GU186068](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186068)
  4                   3316                   G\>A              *ND1*                4                         GCC\>ACC           Ala\>Thr                p.A4T                   non-syn            1                                              \-
  5                   3335                   T\>C              *ND1*                10                        ATT\>ACT           IsoLeu\>Thr             p.I10T                  non-syn            1                                              \-
  6                   3398                   T\>C              *ND1*                31                        ATA\>ACA           Met\>Thr                p.M31T                  non-syn            2                                              [GU186069](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186069)
  7                   3480                   A\>G              *ND1*                58                        AAA\>AAG           Lys\>Lys                p.K58K                  syn                2                                              \-
  8                   3645                   T\>C              *ND1*                113                       GTT\>GTC           Val\>Val                p.V113V                 syn                1                                              \-
  9                   3741                   C\>T              *ND1*                145                       ACC\>ACT           Thr\>Thr                p.T145T                 syn                1                                              \-
  10                  3826                   T\>C              *ND1*                174                       TTA\>CTA           Leu\>Leu                p.L174L                 syn                1                                              \-
  11                  3921                   C\>T              *ND1*                205                       TCC\>TCT           Ser\>Ser                p.S205S                 syn                2                                              \-
  12                  4216                   T\>C              *ND1*                304                       TAT\>CAT           Tyr\>His                p.Y304H                 non-syn            1                                              \-
  13                  4225                   A\>G              *ND1*                307                       ATA\>GTA           Met\>Val                p.M307V                 non-syn            1                                              \-
  14                  4502                   T\>C              *ND2*                11                        TCT\>TCC           Ser\>Ser                p.S11S                  syn                1                                              [GU186070](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186070)
  15                  4561                   T\>C              *ND2*                31                        GTA\>GCA           Val\>Ala                p.V31A                  non-syn            1                                              \-
  16                  4580                   G\>A              *ND2*                37                        ATG\>ATA           Met\>Iso                p.M37I                  non-syn            1                                              \-
  17                  4615                   A\>G              *ND2*                49                        AAC\>AGC           Asn\>Ser                p.N49S                  non-syn            1                                              [GU186071](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186071)
  18                  4638                   A\>G              *ND2*                57                        ATC\>GTC           Ile\>Val                p.I57V                  non-syn            3                                              [GU186072](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186072)
  19                  4703                   T\>C              *ND2*                78                        AAT\>AAC           Asn\>Asn                p.N78N                  syn                1                                              \-
  20                  4916                   A\>G              *ND2*                149                       CTA\>CTG           Leu\>Leu                p.L149L                 syn                1                                              \-
  21                  4917                   A\>G              *ND2*                150                       AAC\>GAC           Asn\>Asp                p.N150D                 non-syn            1                                              \-
  22                  4944                   A\>G              *ND2*                159                       ATC\>GTC           Ile\>Val                p.I159V                 non-syn            1                                              \-
  23                  5033                   A\>G              *ND2*                188                       GGA\>GGG           Gly\>Gly                p.G188G                 syn                1                                              \-
  24                  5097                   A\>G              *ND2*                210                       ATC\>GTC           Ile\>Val                p.I210V                 non-syn            1                                              [GU186073](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186073)
  25                  5186                   A\>T              *ND2*                239                       TGA\>TGT           Trp\>Cys                p.W239C                 non-syn            4                                              \-
  26                  5252                   G\>A              *ND2*                261                       TTG\>TTA           Leu\>Leu                p.L261L                 syn                1                                              \-
  27                  5360                   C\>T              *ND2*                297                       ATC\>ATT           Ile\>Ile                p.I297I                 syn                1                                              \-
  28                  6011                   T\>C              *CO1*                36                        CTT\>CTC           Leu\>Leu                p.L36L                  syn                1                                              \-
  29                  6023                   G\>A              *CO1*                4O                        GAG\>GAA           Glu\>Glu                p.E40E                  syn                1                                              \-
  30                  6217                   T\>C              *CO1*                105                       TTA\>CTA           Leu\>Leu                p.L105L                 syn                1                                              [GU186074](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186074)
  31                  6290                   C\>T              *CO1*                129                       TAC\>TAT)          Tyr\>Tyr                p.Y129Y                 syn                3                                              \-
  32                  6366                   G\>A              *CO1*                155                       GTC\>ATC           Val\>Ile                p.V155 I                non-syn            3                                              \-
  33                  6584                   C\>T              *CO1*                227                       GAC\>GAT           Asp\>Asp                p.D227D                 syn                1                                              [GU186075](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186075)
  34                  7280                   C\>T              *CO1*                459                       TTC\>TTT           Phe\>Phe                p.F459F                 syn                2                                              [GU186076](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186076)
  35                  7598                   G\>A              *CO2*                5                         GCG\>ACG           Ala\>Thr                p.A5T                   non-syn            1                                              \-
  36                  7746                   A\>G              *CO2*                54                        AAC\>AGC           Asn\>Ser                p.N54S                  non-syn            1                                              [GU186077](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186077)
  37                  7843                   A\>G              *CO2*                86                        ATA\>ATG           Met\>Met                p.M86M                  syn                3                                              \-
  38                  7868                   C\>T              *CO2*                95                        CTT\>TTT           Leu\>Phe                p.L95F                  non-syn            2                                              \-
  39                  7961                   T\>C              *CO2*                126                       TTA\>CTA           Leu\>Leu                p.L126L                 syn                1                                              \-
  40                  7962                   T\>C              *CO2*                126                       TTA\>TCA           Leu\>Ser                p.L126S                 non-syn            1                                              [GU186078](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186078)
  41                  8023                   T\>C              *CO2*                146                       ATT\>ATC           Ile\>Ile                p.I 146 I               syn                1                                              \-
  42                  8116                   A\>G              *CO2*                177                       GGA\>GGG           Gly\>Gly                p.G177G                 syn                1                                              [GU186079](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186079)
  43                  8136                   T\>C              *CO2*                184                       TTC\>TTT           Phe\>Phe                p.F184F                 syn                32                                             \-
  44                  8252                   G\>A              *CO2*                222                       GGG\>GGA           Gly\>Gly                p.G222G                 syn                2                                              \-
  45                  8346                   C\>T              *t RNA Lys*          \-                        \-                 \-                      \-                      \-                 1                                              [GU186096](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186096)
  46                  8396                   A\>G              *ATPase8*            11                        ACC\>GCC           Thr\>Ala                p.T11A                  non-syn            1                                              [GU186091](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186091)
  47                  8485                   G\>A              *ATPase8*            40                        AAG\>AAA           Lys\>Lys                p.K40K                  syn                1                                              [GU186092](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186092)
  48                  8502                   A\>G              ATPase8              46                        AAT\>AGT           Asn\>Ser                p.N46S                  non-syn            1                                              [GU186091](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186091)
  49                  8584                   G\>A              *ATPase6*            20                        GCA\>ACA           Ala\>Thr                p.A20T                  non-syn            2                                              \-
  50                  8658                   C\>T              *ATPase6*            44                        ACC\>ACT           Thr\>Thr                p.T44T                  syn                1                                              [GU186080](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186080)
  51                  8684                   C\>T              *ATPase6*            53                        ACC\>ATC           Thr\>Ile                p.T53I                  non-syn            1                                              \-
  52                  8697                   G\>A              *ATPase6*            57                        ATG\>ATA           Met\>Met                p.M57M                  syn                1                                              \-
  53                  8701                   G\>A              *ATPase6*            59                        GCC\>ACC           Ala\>Thr                p.A59T                  non-syn            15                                             \-
  54                  8843                   T\>A              *ATPase6*            106                       ATC\>ACC           Ile\>Ile                p.I106 I                syn                2                                              \-
  55                  8865                   G\>A              *ATPase6*            113                       GTG\>GTA           Val\>Val                p.V113V                 syn                2                                              \-
  56                  8875                   T\>C              *ATPase6*            117                       TTT\>CTT           Phe\>Thr                p.F117T                 non-syn            1                                              [GU186081](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186081)
  57                  8886                   G\>A              *ATPase6*            120                       AAG\>AAA           Lys\>Lys                p.K120K                 syn                35                                             [GU186095](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186095)
  58                  8887                   A\>G              *ATPase6*            121                       ATT\>GTT           Ile\>Val                p.I121V                 non-syn            1                                              \-
  59                  8925                   A\>G              *ATPase6*            133                       ACA\>ACG           Thr\>Thr                p.T133T                 syn                1                                              \-
  60                  8928                   T\>C              *ATPase6*            138                       ATC\>ACC           Ile\>Thr                p.I138T                 non-syn            1                                              \-
  61                  8943                   C\>T              *ATPase6*            139                       CCC\>CCT           Pro\>Pro                p.P139P                 syn                1                                              \-
  62                  9064                   G\>A              *ATPase6*            180                       GCA\>ACA           Ala\>Thr                p.A180T                 non-syn            2                                              \-
  63                  9072                   A\>G              *ATPase6*            183                       TCA\>TCG           SerSer                  p.S183S                 syn                1                                              \-
  64                  9094                   C\>T              *ATPase6*            190                       CTT\>TTT           Leu\>Phe                p.L190F                 non-syn            1                                              \-
  65                  9110                   T\>C              *ATPase6*            195                       ATT\>ACT           Ile\>Thr                p.I195T                 non-syn            1                                              \-
  66                  9287                   G\>A              *CO3*                27                        ATG\>ATA           Met\>Met                p.M27M                  syn                1                                              [GU186089](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186089)
  67                  9377                   G\>A              *CO3*                57                        TGA\>TGG           Trp\>Trp                p.W57W                  syn                19                                             \-
  68                  9540                   C\>T              *CO3*                112                       CTA\>TTA           Leu\>Leu                p.L112L                 syn                9                                              \-
  69                  9614                   A\>G              *CO3*                136                       GTA\>GTG           Val\>Val                p.V136V                 syn                1                                              \-
  70                  9698                   T\>C              *CO3*                164                       CTT\>CTC           Leu\>Leu                p.L164L                 syn                1                                              \-
  71                  9716                   T\>C              *CO3*                170                       GGT\>GGC           Gly\>Gly                p.G170G                 syn                1                                              \-
  72                  9767                   C\>T              *CO3*                183                       ACC\>ACT           Thr\>Thr                p.T187T                 syn                1                                              \-
  73                  9768                   T\>C              *CO3*                184                       TCT\>TCC           Ser\>Ser                p.S184S                 syn                1                                              \-
  74                  9967                   G\>A              *CO3*                254                       GTC\>ATC           Val\>Ile                p.V254I                 non-syn            1                                              [GU186090](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186090)
  75                  10142                  C\>T              *ND3*                28                        AAC\>AAT           Asn\>Asn                p.N28N                  syn                1                                              \-
  76                  10181                  C\>T              *ND3*                41                        TTC\>TTT           Phe\>Phe                p.F41F                  syn                1                                              \-
  77                  10365                  G\>C              *ND3*                103                       GCC\>ACC           Ala\>Thr                p.A103T                 non-syn            1                                              \-
  78                  10398                  G\>A              *ND3*                114                       GCC\>ACC           Ala\>Thr                p.A114T                 non-syn            16                                             \-
  79                  10400                  C\>T              *ND3*                114                       GCC\>GCT           Ala\>Ala                p.A114A                 syn                12                                             \-
  80                  10410                  T\>A              *tRNA Arg*           \-                        \-                 \-                      \-                      \-                 1                                              \-
  81                  10463                  T\>C              *tRNA Arg*           \-                        \-                 \-                      \-                      \-                 1                                              \-
  82                  10490                  T\>C              *ND4L*               7                         AAT\>AAC           Asn\>Asn                p.N7N                   syn                1                                              [GU186094](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186094)
  83                  10550                  A\>G              *ND4L*               27                        ATA\>ATG           Met\>Met                p.M27M                  syn                1                                              \-
  84                  11467                  A\>G              *ND4*                236                       TTA\>TTG           Leu\>Leu                p.L236L                 syn                2                                              \-
  85                  11719                  A\>G              *ND4*                320                       GGA\>GGG           Gly\>Gly                p.G320G                 syn                2                                              \-
  86                  12007                  G\>A              *ND4*                416                       TGG\>TGA           Trp\>Trp                p.W416W                 syn                5                                              \-
  87                  12031                  C\>T              *ND4*                424                       AAC\>AAT           Asn\>Asn                p.N424N                 syn                1                                              [GU186088](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186088)
  88                  12097                  C\>T              *ND4*                446                       CTC\>CTT           Leu\>Leu                p.L446L                 syn                2                                              \-
  89                  12106                  C\>T              *ND4*                449                       CTC\>CTT           Leu\>Leu                p.L449L                 syn                1                                              \-
  90                  12130                  T\>C              *ND4*                457                       TTT\>TTC           Phe\>Phe                p.F457F                 syn                1                                              [GU186087](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186087)
  91                  12308                  A\>G              *tRNA Leu*           \-                        \-                 \-                      \-                      \-                 3                                              \-
  92                  12372                  G\>A              *ND5*                12                        CTG\>CTA           Leu\>Leu                p.L12L                  syn                4                                              \-
  93                  12477                  T\>C              *ND5*                47                        AGT\>AGC           Ser\>Ser                p.S47S                  syn                1                                              \-
  94                  12498                  C\>T              *ND5*                54                        TTC\>TTT           Phe\>Phe                p.F54F                  syn                2                                              \-
  95                  12561                  G\>A              *ND5*                75                        CAG\>CAA           Gln\>Gln                p.Q75Q                  syn                1                                              \-
  96                  12681                  T\>C              *ND5*                115                       AAT\>AAC           Asn\>Asn                p.N115N                 syn                1                                              \-
  97                  12705                  T\>C              *ND5*                123                       ATT\>ATC           Ile\>Ile                p.I123 I                syn                10                                             \-
  98                  12793                  T\>C              *ND5*                153                       TTG\>CTG           Leu\>Leu                p.L153L                 syn                1                                              GU186084
  99                  12810                  A\>G              *ND5*                158                       TGA\>TGG           Trp\>Trp                p.W158W                 syn                1                                              \-
  100                 12849                  A\>T              *ND5*                171                       GCA\>GCT           Ala\>Ala                p.A171A                 syn                8                                              [GU186085](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186085)
  101                 12879                  T\>C              *ND5*                181                       GGT\>GGC           Gly\>Gly                p.G181G                 syn                1                                              \-
  102                 12906                  C\>T              *ND5*                190                       ATC\>ATT           Ile\>Ile                p.I190I                 syn                1                                              [GU186082](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186082)
  103                 13020                  T\>C              *ND5*                228                       GGT\>GGC           Gly\>Gly                p.G228G                 syn                1                                              \-
  104                 13135                  G\>A              *ND5*                267                       GCA\>ACA           Ala\>Thr                p.A267T                 non-syn            1                                              \-
  105                 13138                  G\>A              *ND5*                268                       GAA\>AAA           Glu\>Lys                p.E268K                 non-syn            20                                             [GU186083](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186083)
  106                 13188                  C\>T              *ND5*                284                       ACC\>ACT           Thr\>Thr                p.T284T                 syn                1                                              \-
  107                 13194                  G\>A              *ND5*                286                       CTG\>CTA           Leu\>Leu                p.L286L                 syn                1                                              \-
  108\.               13215                  T\>C              *ND5*                293                       CTT\>CTC           Leu\>Leu                p.L293L                 syn                1                                              \-
  109                 13368                  G\>A              *ND5*                344                       GGG\>GGA           Gly\>Gly                p.G344G                 syn                1                                              \-
  110                 13500                  T\>C              *ND5*                388                       GGT\>GGC           Gly\>Gly                p.G388G                 syn                1                                              \-
  111                 13539                  A\>G              *ND5*                401                       ATA\>ATG           Met\>Met                p.M401M                 syn                2                                              \-
  112                 13542                  A\>G              *ND5*                402                       TCA\>TCG           Ser\>Ser                p.S402S                 syn                1                                              \-
  113                 13651                  A\>G              *ND5*                439                       ACC\>GCC           Thr\>Ala                p.T439A                 non-syn            1                                              \-
  114                 13656                  T\>C              *ND5*                440                       CTT\>CTC           Leu\>Leu                p.L440L                 syn                4                                              \-
  115                 13708                  G\>A              *ND5*                458                       GCA\>ACA           Ala\>Thr                p.A458T                 non-syn            1                                              \-
  116                 13768                  T\>C              *ND5*                478                       TTC\>CTC           Phe\>Leu                p.F478L                 non-syn            1                                              [GU186086](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186086)
  117                 14000                  T\>A              *ND5*                555                       CCT\>CCA           Leu\>Pro                p.L555P                 non-syn            2                                              \-
  118                 14022                  A\>G              *ND5*                562                       TTA\>TTG           Leu\>Leu                p.L562L                 syn                1                                              \-
  119                 14935                  T\>C              *CYB*                63                        TTT\>TTC           Phe\>Phe                p.F63F                  syn                1                                              \-
  120                 15038                  A\>G              *CYB*                98                        ATC\>GTC           Ile\>Val                p.I98V                  non-syn            1                                              \-
  121                 15043                  G\>A              *CYB*                99                        GGG\>GGA           Gly\>Gly                p.G99G                  syn                12                                             \-
  122                 15061                  A\>G              *CYB*                105                       GGA\>GGG           Gly\>Gly                p.G105G                 syn                1                                              \-
  123                 15097                  T\>C              *CYB*                117                       ATT\>ATC           Ile\>Ile                p.I117I                 syn                1                                              \-
  124                 15148                  G\>A              *CYB*                134                       CCG\>CCA           Pro\>Pro                p.P134P                 syn                3                                              \-
  125                 15301                  G\>A              *CYB*                185                       TTG\>TTA           Leu\>Leu                p.L185L                 syn                16                                             \-
  126                 15317                  G\>A              *CYB*                191                       GCC\>ACC           Ala\>Thr                p.A191T                 non-syn            1                                              \-
  127                 15452                  C\>A              *CYB*                236                       CTT\>ATT           Leu\>Ile                p.L236 I                non-syn            2                                              \-
  128                 15607                  A\>G              *CYB*                287                       AAA\>AAG           Lys\>Lys                p.K287K                 syn                1                                              \-
  129                 15670                  T\>C              *CYB*                308                       CAT\>CAC           His\>His                p.H308H                 syn                1                                              \-
  130                 15683                  A\>G              *CYB*                312                       CAA\>CAG           Gln\>Gln                p.Q312Q                 syn                2                                              [GU186093](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU186093)
  131                 At 15928               G\>A              *t RNA Thr*          \-                        \-                 \-                      \-                      \-                 1                                              \-
  132                 At 15930               G\>A              *t RNA Thr*          \-                        \-                 \-                      \-                      \-                 1                                              \-

Key: A -- Adenine; T -- Thymine; G- Guanine; C- Cytosine; Syn- synonymous; Non-syn- non-synonymous; \*- novel change; *ND1*- NADH dehydrogenase subunit 1; *ND2*- NADH dehydrogenase subunit 2; *ND3*- NADH dehydrogenase subunit 3; *ND4*- NADH dehydrogenase subunit 4; *ND4L*- NADH dehydrogenase subunit 4L; *ND5*- NADH dehydrogenase subunit 5; *CO1*- cytochrome c oxidase I; *CO2*- cytochrome c oxidase II; *CO3*- cytochrome c oxidase III; *ATPase6*- ATP synthase subunit a (F-ATPase protein 6); *ATPase8*- ATP synthase protein 8; *CYB*- cytochrome B; *tRNA*- transfer ribo nucleic acid; *rRNA*- ribosomal ribonucleic acid.

###### Mitochondrial DNA variations observed in controls.

  **Sample number**   **Genomic position**   **Base change**   **Gene/ Location**   **Amino acid position**   **Codon change**   **Amino acid change**   **Change in protein**   **Syn/ Non-syn**   **GenBank accession number if novel**
  ------------------- ---------------------- ----------------- -------------------- ------------------------- ------------------ ----------------------- ----------------------- ------------------ -----------------------------------------------------------------------------------
  1                   3591                   G\>A              *ND1*                95                        CTG\>CTA           Thr\>Thr                p.T95T                  syn                \-
  2                   3915                   G\>A              *ND1*                203                       GGG\>GGA           Gly\>Gly                p.G203G                 syn                \-
  3                   3918                   G\>A              *ND1*                204                       GAG\>GAA           Glu\>Glu                p.E204E                 syn                \-
  4                   3933                   A\>G              *ND1*                209                       TCA\>TCG           Ser\>Ser                p.S209S                 syn                [GU397544](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397544)
  5                   3970                   C\>T              *ND1*                222                       CTA\>TTA           Leu\>Leu                p.L222L                 syn                \-
  6                   3996                   C\>T              *ND1*                230                       AAC\>AAT           Asn\>Asn                p.N230N                 syn                \-
  7                   4029                   C\>A              *ND1*                241                       ATC\>ATA           Ile\>Ile                p.I241I                 syn                [GU397545](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397545)
  8                   4093                   A\>G              *ND1*                263                       ACC\>GCC           Thr\>Ala                p.T263A                 non-syn            \-
  9                   4793                   A\>G              *ND2*                108                       ATA\>ATG           Met\>Met                p.M108M                 syn                \-
  10                  4852                   T\>A              *ND2*                128                       CTG\>CAG           Leu\>Gln                p.L128Q                 non-syn            [GU397533](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397533)
  11                  5186                   A\>T              *ND2*                239                       TGA\>TGT           Trp\>Cys                p.W239C                 non-syn            \-
  12                  5348                   C\>T              *ND2*                293                       TAC\>TAT           Tyr\>Tyr                p.Y293Y                 syn                \-
  13                  5351                   A\>G              *ND2*                294                       CTA\>CTG           Leu\>Leu                p.L294L                 syn                \-
  14                  6305                   G\>A              *CO1*                134                       GGG\>GGA           Gly\>Gly                p.G134G                 syn                \-
  15                  6719                   T\>C              *CO1*                272                       GGT\>GGC           Gly\>Gly                p.G272G                 syn                \-
  16                  6962                   G\>A              *CO1*                353                       CTG\>CTA           Thr\>Thr                p.T353T                 syn                \-
  17                  7316                   G\>A              *CO1*                471                       ATG\>ATA           Met\>Met                p.M471M                 syn                --
  18                  7738                   T\>C              *CO2*                51                        ACT\>ACC           Thr\>Thr                p.T51T                  syn                \-
  19                  7762                   G\>A              *CO2*                59                        CAG\>CAA           Gln\>Gln                p.Q59Q                  syn                \-
  20                  8143                   T\>C              *CO2*                186                       GCT\>GCC           Ala\>Ala                p.A186A                 syn                [GU397549](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397549)
  21                  8251                   G\>A              *CO2*                222                       GGG\>GGA           Gly\>Gly                p.G222G                 syn                \-
  22                  8503                   T\>G              *ATP8*               46                        AAT\>AAG           Asp\>Lys                p.N46K                  non-syn            [GU397551](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397551)
  23                  8584                   G\>A              *ATP6*               20                        GCA\>ACA           Ala\>Thr                p.A20T                  non-syn            \-
  24                  8594                   T\>C              *ATP6*               23                        ATC\>ACC           Ile\>Thr                p.I23T                  non-syn            \-
  25                  8650                   C\>T              *ATP6*               42                        CTA\>TTA           Leu\>Leu                p.L42L                  syn                \-
  26                  8718                   A\>G              *ATP6*               64                        AAA\>AAG           Lys\>Lys                p.K64K                  syn                \-
  27                  8812                   A\>G              *ATP6*               96                        ACC\>GCC           Thr\>Ala                p.T96A                  non-syn            \-
  28                  8886                   G\>A              *ATP6*               120                       AAG\>AAA           Lys\>Lys                p.K120K                 syn                [GU397552](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397552)
  29                  8925                   A\>G              *ATP6*               133                       ACA\>ACG           Thr\>Thr                p.T133T                 syn                \-
  30                  10310                  G\>A              *ND3*                84                        CTG\>CTA           Thr\>Thr                p.T84T                  syn                \-
  31                  10609                  T\>C              *ND4L*               47                        ATA\>ACA           Met\>Thr                p.M47T                  non-syn            \-
  32                  11467                  A\>G              *ND4*                236                       TTA\>TTG           Leu\>Leu                p.L236L                 syn                \-
  33                  11914                  G\>A              *ND4*                385                       ACG\>ACA           Thr\>Thr                p.T385T                 syn                \-
  34                  12007                  G\>A              *ND4*                416                       TGG\>TGA           Trp\>Trp                p.W416W                 syn                \-
  35                  12073                  C\>T              *ND4*                438                       TTC\>TTT           Phe\>Phe                p.F438F                 syn                [GU397542](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397542)
  36                  12107                  C\>T              *ND4*                449                       CTC\>CTT           Thr\>Thr                p.T449T                 syn                [GU397543](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397543)
  37                  12133                  C\>T              *ND4*                458                       TCC\>TCT           Ser\>Ser                p.S458S                 syn                \-
  38                  12372                  G\>A              *ND5*                12                        CTG\>CTA           Tyr\>Tyr                p.T12T                  syn                \-
  39                  12373                  A\>G              *ND5*                13                        ACT\>GCT           Thr\>Ala                p.T13A                  non-syn            \-
  40                  12406                  G\>A              *ND5*                24                        GTT\>ATT           Val\>Ile                p.V24I                  non-syn            \-
  41                  12486                  C\>T              *ND5*                50                        CCC\>CCT           Pro\>Pro                p.P50P                  syn                [GU397534](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397534)
  42                  12498                  C\>T              *ND5*                54                        TTC\>TTT           Phe\>Phe                p.F54F                  syn                [GU397538](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397538)
  43                  12561                  G\>A              *ND5*                75                        CAG\>CAA           Gln\>Gln                p.Q75Q                  syn                \-
  44                  13204                  G\>A              *ND5*                290                       GTC\>ATC           Val\>Ile                p.V290I                 non-syn            [GU397535](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397535)
  45                  13299                  A\>G              *ND5*                321                       CAA\>CAG           Gln\>Gln                p.Q321Q                 syn                \-
  46                  13676                  A\>G              *ND5*                447                       AAC\>AGC           Asn\>Ser                p.N447S                 non-syn            [GU397540](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397540)
  47                  13731                  A\>G              *ND5*                465                       GGA\>GGG           Gly\>Gly                p.G465G                 syn                \-
  48                  13860                  C\>T              *ND5*                490                       GCC\>GCT           Ala\>Ala                p.A490A                 syn                [GU397541](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397541)
  49                  14058                  C\>T              *ND5*                574                       TCC\>TCT           Ser\>Ser                p.S574S                 syn                \-
  50                  14783                  T\>C              *CYB*                13                        TTA\>CTA           Leu\>Leu                p.L13L                  syn                \-
  51                  14872                  C\>T              *CYB*                42                        ATC\>ATT           Ile\>Ile                p.I42I                  syn                \-
  52                  15119                  G\>A              *CYB*                125                       GCA\>ACA           Ala\>Thr                p.A125T                 non-syn            \-
  53                  15172                  G\>A              *CYB*                142                       GGG\>GGA           Gly\>Gly                p.G142G                 syn                \-
  54                  15217                  G\>A              *CYB*                157                       GGG\>GGA           Gly\>Gly                p.G157G                 syn                \-
  55                  15385                  C\>T              *CYB*                213                       TCC\>TCT           Ser\>Ser                p.S213S                 syn                \-
  56                  15431                  G\>A              *CYB*                229                       GCC\>ACC           Ala\>Thr                p.A229T                 non-syn            \-
  57                  15484                  A\>G              *CYB*                246                       TCA\>TCG           Ser\>Ser                p.S246S                 syn                [GU397547](http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=GU397547)
  58                  15670                  T\>C              *CYB*                308                       CAT\>CAC           His\>His                p.H308H                 syn                \-

Key: A -- Adenine; T -- Thymine; G- Guanine; C- Cytosine; Syn- synonymous; Non-syn- non-synonymous; ND1- NADH dehydrogenase subunit 1; ND2- NADH dehydrogenase subunit 2; ND3- NADH dehydrogenase subunit 3; ND4- NADH dehydrogenase subunit 4; ND4L- NADH dehydrogenase subunit 4L; ND5- NADH dehydrogenase subunit 5; CO1- cytochrome c oxidase I; CO2- cytochrome c oxidase II; CO3- cytochrome c oxidase III; ATPase6- ATP synthase subunit a (F-ATPase protein 6); ATPase8- ATP synthase protein 8; CYB- cytochrome B.

![Bar diagram showing distribution of nucleotide variations in different mitochondrial genes in PCG. Abbrevations: ND1- NADH dehydrogenase subunit 1; ND2- NADH dehydrogenase subunit 2; ND3- NADH dehydrogenase subunit 3; ND4- NADH dehydrogenase subunit 4; ND4L- NADH dehydrogenase subunit 4L; ND5- NADH dehydrogenase subunit 5; CO1- cytochrome c oxidase I; CO2- cytochrome c oxidase II; CO3- cytochrome c oxidase III; ATPase6- ATP synthase subunit a (F-ATPase protein 6); ATPase8- ATP synthase protein 8; CYB- cytochrome B; tRNA- transfer ribo nucleic acid; rRNA- ribosomal ribonucleic acid.](mv-v16-518-f1){#f1}

Two non-synonymous changes (p.W239C in *ND2* and p.A20T in *ATPase6*) were present both in cases as well as controls. The remaining 40 non-synonymous changes were limited to PCG cases only. All novel variations from patients and controls were submitted to the GenBank database and accession numbers were obtained ([Table 1](#t1){ref-type="table"} and [Table 2](#t2){ref-type="table"}).

[SIFT](http://sift.jcvi.org/) and [PolyPhen](http://genetics.bwh.harvard.edu/pph) analysis of all non-synonymous changes from cases and controls revealed five pathogenic changes (p.P2L, p.I10T, p.M31T in ND1 protein and p.M37I, p.W239C in ND2 protein). Eight patients (22.85%) were positive for either of these pathologic mtDNA nucleotide changes. Clinical features of patients and mtDNA variations identified in this study have been tabulated ([Table 3](#t3){ref-type="table"}).

###### Mitochondrial DNA variations and clinical features of primary congenital glaucoma patients.

                       **Sequence variations in different mitochondrial genes**                                                                                                                                                                                                                                                                                                                                                                                                                                             
  -------------------- ---------------------------------------------------------- ------------------ ------------------ ------------------ ---------------- -------------------------- ---------------------------------- ------------------ ------------ ----------- ------------------------------------------------------ ---------------------------------- ----------------------------------------------------------------------- ------------------------------------------------- --------------------------------- ----------------------
  **Patient number**   ***ND1***                                                  ***ND2***          ***CO1***          ***CO2***          ***ATPase8***    ***ATPase6***              ***CO3***                          ***ND3***          ***ND4L***   ***ND4***   ***ND5***                                              ***CYB***                          **Other changes**                                                       **Last cup disc ratio (OS/OD) at presentation**   **Corneal diameter (mm) OS/OD**   **IOP (mmHg) OS/OD**
  1                    --                                                         --                 p.Y129Y; p.F459F   p.M86M; p.L95F     --               p.A20T; p.A59T             p.W57W; p.L112L                    p.A114T            \-           --          p.I123I; p.E268K; p.M401M; p.L555P                     p.P134P; p.L185L                   Ins. of T at 2790_91 (16sRNA)                                           Total cupping                                     15x15/15x15.5                     40/30
  2                    --                                                         --                 p.Y129Y; p.F459F   p.M86M; p.L95F     --               p.A20T; p.A59T             p.W57W; p.L112L                    p.A114T            \-           --          p.I123I; p.E268K; p.M401M; p.L555P                     p.P134P; p.L185L                   Ins. of T at 2790_91 (16sRNA)                                           0.8:1/0.8:1                                       13x13/13x13                       36/40
  3                    p.M31T                                                                        p.V155 I                              --               p.V113V                    p.W57W                             p.A114A            \-           p.W416W     p.E268K                                                p.G99G                             \-                                                                      Hazy MEDIA                                        15x14/15x15                       26/38
  4                    --                                                         --                 p.D227D            G222G              --               I195T                      W57W                               A114A              \-           p.W416W     p\. E268K                                              p.A191T; p.Q312Q                   \-                                                                      0.4:1/0.4:1                                       12x11/12x12                       22/24
  5                    --                                                         --                 --                 p.N54S             --               p.A59T                     p.W57W; p.L112L                    p.A114T            \-                       p.I190I; p.E268K                                       p.G99G; p.L185L                    \-                                                                      0.7:1/0.7:1                                       14.5x15/15x15                     28/28
  6                    p.Y304H; p.M307V                                           p.N150T            --                 --                                  p.M57M                     p.W57W; p.L112L                    p.A114T            \-           --          p\. I123I; p.E268K; p.G344G                            p.L236I; p.K287Q                   \-                                                                      0.5:1/0.5:1                                       12x13/12x13                       22/23
  7                    --                                                         --                 --                 p.I146I; p.F184F   --               p.A59T; p.P139P            p.M27M; p.W57W; p.L112L; p.T187T   p.A114T            \-           p.L236L     p.I123I; p.E268K                                       p.F63F; p.G99G; p.G105G; p.L185L   A\>G at 12308 tRNA Leu                                                  0.4:1/0.4:1                                       12x13/11x11.5                     38/14
  8                    --                                                         --                 --                 p.G177G            --               --                         p.W57W                             p.A114A            \-           --          p.Q75Q; p.E268K                                        p.G99G                             G\>A at 15928 (t RNA Thr)                                               Hazy media                                        NA                                23/25
  9                    p.L174L; p.S205S                                           --                 --                 --                 --               --                         p.W57W                             p.A114A            \-           --          p.I123I; p.V172I; p.E268K; p.L293L                     p.G99G                             C\>T at 8346 (t RNA Lys)                                                NA                                                12x12/12x12                       22/22
  10                   p.V113V; p.T145T                                           p.S11S; p.I297I                       L126S; F184F                        p.I106I; p.T53 I           p.W57W; p.L112L                    p.N28N; p.A114T    \-           p.L236L     p.I123I; p.E268K; p.G388G                              --                                 A\>G at 12308 tRNA Leu                                                  NA                                                NA                                23/24
  11                   --                                                         p.W239C            p.L105T            --                 --               p.A59T; p.L190F            p.W57W; p.L112L; p.V136V           p.A114T            \-           p.L449L     p.I123I; p.L153L; p.E268K; p.L286L                     p.L185L                            G\>A at 2707 (16sRNA); A\>G at 12308 tRNA Leu; G\>A at 15930 tRNA Arg   NA                                                14x14/14x15                       26/22
  12                   p.P2L                                                      p.N49S             --                 --                 --               A59T; I106I                --                                 p.A114T            \-           p.G320G     p.N115N; p.I123I; p.E268K; p.L440L; p.A458T; p.F478L   p.L185L                            \-                                                                      NA                                                14x14.5/14x14.4                   32/32
  13                   p.M31T                                                     --                 p.V155 I           --                 --               p.V113V                    p.W57W                             p.A114A            \-           p.W416W     p.A171A; E268K                                         p.G99G                             \-                                                                      Hazy media                                        14x14/14x14                       31/30
  14                   --                                                         --                 --                 --                 --               p.S183S                    p.W57W                             p.A114A            \-           p.W416W     p.A171A; p.E268K; p.T284T                              p.G99G                             \-                                                                      Hazy media                                        NA                                25/24
  15                   --                                                         p.L261L            --                 p.L126L            p.T11A; p.N46S   --                         p.W57W; p.S184S                    p.A114A            \-           --          p.A171A; p.E268K                                       p.G99G; p.H308H                    \-                                                                      0.6:1/0.6:1                                       14.5x14/13.5x13                   32/32
  16                   --                                                         --                 --                 --                 p.K40K           --                         p.W57W                             p.A114A            \-           p.W416W     p.F54F; p.A171A; p.A267T; p.E268K                      p.G99G                             \-                                                                      0.4:1/0.5:1                                       11x11/12x12.5                     18/26
  17                   p.S205S                                                    --                 --                 --                 --               p.T44T                     p.W57W                             p.A114A            \-           p.F457F     S47S; A171A; G181G; E268K                              p.G99G                             \-                                                                      NA                                                14x14/14x14.5                     30/28
  18                   --                                                         --                 --                 --                 --               p.A59T                     p.W57W; p.L112L                    p.A114T            \-           p.G320G     p.I123I; p.A171A; p.E268K                              p.L185L; p.Q312Q                   \-                                                                      NA                                                14.5x14/14x14                     20/20
  19                   --                                                         --                 p.V155 I           p.A5T              --               p.F17T; p.A180T            p.W57W                             p.A103T; p.A114A   \-           --          p.A171A; p.G228G; p.E268K                              p.G99G                             \-                                                                      0.5:1 1                                           12x12.5/12x12                     22/22
  20                   p.I10T                                                     --                 p.Y129Y            p.M86M             --               p.A59T                     p.W57W; p.L112L                    p.A114T            \-           --          p.I123I; p.V172I                                       p.I98V; p.P134P; p.L185L           \-                                                                      Hazy media                                        12x13/13x13                       18/37
  21                   --                                                         p.I59V             --                 --                 --               p.K120K                    --                                 --                 \-           p.L446L     --                                                     p.L185L                            \-                                                                      Hazy media                                        15x16/11.5x12                     32/15
  22                   --                                                         --                 --                 p.G222G            --               p.K120K                                                       p.A114A            \-           \-          --                                                                                        \-                                                                      0.7:1/0.5:1                                       15x15/16x16                       28/28
  23                   p.K58K                                                     p.V31A                                --                 --               p.A59T; p.K120K            p.L164L; p.G170G                   p.A114T            p.M27M       \-          p.L12L                                                 p.L185L                            \-                                                                      Hazy media                                        14x15/14x15                       34/36
  24                   --                                                                            --                 --                 --               p.A59T; p.K120K; p.P134P   \-                                                    \-           \-          --                                                     p.L185L; p.L236I                   T\>A at 10411 (t RNA Arg)                                               0.7:1/0.7:1                                       NA                                32/10
  25                   --                                                         p.I57V; p.W239C    --                 --                 --               p.A59T; p.K120K            \-                                 p.A114T            \-           \-          p.L12L; p.L440L                                        --                                 \-                                                                      NA                                                14x15/14x15                       22/22
  26                   --                                                         p.I57V; p.W239C    --                 --                 --               p.A59T; p.K120K            \-                                 p.A114T            \-           \-          p.L12L; p.L440L                                        --                                 \-                                                                      Hazy media                                        13x13.5/15x14.5                   22/22
  27                   --                                                         p.L149L; p.G188G   --                 --                 --               p.K120K                    \-                                 p.A114A            \-           \-          p.T439A                                                p.L185L                            \-                                                                      0.8:1/0.8:1                                       13x13.5/13x13.5                   20/20
  28                   --                                                         p.M37I; p.N78N     --                 --                 --               p.K120K                    \-                                 p.A114A            \-           \-          --                                                     p.G99G                             \-                                                                      hazy media                                        14x14/14x14                       22/24
  29                   --                                                         --                 p.E40E             --                 --               p.A59T; p.K120K            \-                                 p.A114T            p.N7N        \-          --                                                     --                                 \-                                                                      NA                                                14x14/11x11                       18/22
  30                   p.A4T                                                      --                 --                 --                 --               p.K120K ; p.I121V          V254I                              p.F41F; p.A114T    \-           p.N424N     --                                                     p.L185L                            \-                                                                      Hazy media                                        corneal ulcer/14x14               18/20
  31                   --                                                         p.I210V            p.L36L             --                 --               p.K120K                    \-                                 p.A114A            \-           \-          --                                                     p.I117I                            \-                                                                      Hazy media                                        12x10/12x12.5                     40/26
  32                   --                                                         p.I57V; p.W239C    --                 --                 --               p.A59T; p.K120K; p.A180T   \-                                 p.A114T            \-           \-          p.L12L                                                 p.L185L                            \-                                                                      0.8:1 1                                           12x12/12x12                       22/26
  33                   --                                                         --                 --                 --                 --               p.K120K                    \-                                 --                 \-           \-          --                                                     p.L185L                            \-                                                                      0.8:1/0.9:1                                       14x14/14x14                       26/24
  34                   --                                                         --                 --                 \-                 \-               p.K120K; p.T133T           \-                                 p.A114A            \-           \-          p.S402S                                                --                                 \-                                                                      0.5:1/0.5:1                                       12x12/12x12.5                     20/22
  35                   p.K58K                                                     --                 --                 --                 --               p.K120K                    \-                                 p.A114A            \-           p.L446L     --                                                     --                                 --                                                                      0.5:1/0.3:1                                       13x13/13x13.5                     24/16

Key: NA- not available; OD- right eye; OS- left eye; OU- both eyes; mmHg- milimeter of mercury; IOP- intra ocular pressure; Syn- synonymous; Non-syn- non-synonymous; - novel change; *ND1*- NADH dehydrogenase subunit 1; *ND2*- NADH dehydrogenase subunit 2; *ND3*- NADH dehydrogenase subunit 3; *ND4*- NADH dehydrogenase subunit 4; *ND4L*- NADH dehydrogenase subunit 4L; *ND5*- NADH dehydrogenase subunit 5; *CO1*- cytochrome c oxidase I; *CO2*- cytochrome c oxidase II; *CO3*- cytochrome c oxidase III; *ATPase6*- ATP synthase subunit a (F-ATPase protein 6) ; *ATPase8*- ATP synthase protein 8; *CYB*- cytochrome B; tRNA- transfer ribo nucleic acid.

Discussion
==========

The human mtDNA is a 16,569-base pair double-stranded, compact, circular molecule which lacks histones and is without introns. MtDNA has several overlapping genes and incomplete termination codons. It contains 37 genes which regulate oxidative phosphorylation (OXPHOS). Of these, 24 are needed for mtDNA translation (2 rRNAs \[rRNAs\] and 22 tRNAs \[tRNAs\]), and 13 encode subunits of the respiratory chain: seven subunits of complex I (ND1, 2, 3, 4, 4L, 5, and 6 \[ND stands for NADH dehydrogenase\]), one subunit of complex III (cytochrome b), three subunits of cytochrome c oxidase (COX I, II, and III), and two subunits of ATP synthase (ATPase6 and ATPase8; [Figure 2](#f2){ref-type="fig"}).

![Schematic representation of components of the OXPHOS pathway localized in inner mitochondrial membrane.](mv-v16-518-f2){#f2}

MtDNA mutates 10 times more frequently as compared to nuclear DNA due to its proximity to the electron transport chain (ETC) and lack of histones and other protective proteins and has very basic repair mechanism \[[@r23]\]. Mitochondria are essential for ATP production by OXPHOS and are susceptible to oxidative damage because reactive oxygen species (ROS) damage mitochondrial enzymes directly and alter mitochondrial membrane permeability leading to cell death \[[@r24]\]. Most studies suggest that the majority of intracellular ROS produced by non-phagocytic cells are derived from mitochondria \[[@r25],[@r26]\]. Thus mitochondria are both source and target of free radicals.

Several human diseases have been associated with mtDNA mutations, indicating that dysfunction of the components of oxidative phosphorylation encoded by the mitochondrial genome can be deleterious \[[@r27]\]. Abnormalities in mtDNA have proven to be associated with leber's hereditary optic neuropathy (LHON) \[[@r28]\], POAG, pseudoexfoliation glaucoma (PEG), primary angle closure glaucoma (PACG), other spontaneous optic neuropathies \[[@r11],[@r13],[@r14],[@r29]\], and male infertility \[[@r15]\].

In this study we screened 35 PCG cases for mtDNA variations. We found 42 non-synonymous mtDNA variations in PCG patients in different mitochondrial genes. The highest number of nucleotide variations were recorded in complex I, followed by complex IV and then complex V. Eight patients (22.85%) were found to be positive for pathogenic changes while in PEG patients this was 10.30% \[[@r14]\].

Complex I is responsible for pumping of protons (H^+^) from the matrix to the inter-membrane space in association with complex III and IV. Although the mitochondrial ETC is very effective in the reduction of oxygen to water, there is a constant "leak" of electrons from the ETC to oxygen and this results in the formation of superoxide anions. It is generally agreed that there are two main sites in the respiratory chain where superoxide anions are generated viz. complex I and complex III \[[@r30],[@r31]\]. Dismutation of superoxide anions produces hydrogen peroxide as a secondary product, and in the presence of transition metals this can be converted to a highly reactive hydroxyl radical that can readily oxidize proteins, lipids, carbohydrates, DNA, and RNA \[[@r32]\]. Fifty percent nucleotide variations identified in our study were in complex I.

[SIFT](http://sift.jcvi.org/) and [PolyPhen](http://genetics.bwh.harvard.edu/pph) analysis of missense changes showed that p.P2L, p.I10T, and p.M31T in ND1 protein and p.M37I and p.W239C in ND2 protein were deleterious to protein function. PHAT (predicted hydrophobic and transmembrane) score difference of p.P2L and p.I10T was \>2 and PSIC score of p.M31T was \>2. PSIC score of p.M37I and W239C was \>2 and \>1.5, respectively. All these changes (p.P2L, p.I10T, and p.M31T in *ND1* and p.M37I and p.W239C in *ND2*) had [SIFT](http://sift.jcvi.org/) scores \<0.05 and were predicted to be deleterious. Pathogenic variants p.P2L, p.I10T, and p.M31T were present in 3 cases (1 case each) while p.M37I and p.W239C were present in one and four cases, respectively. However, frequency of the pathogenic variants (p.P2L, p.I10T, and p.M31T in *ND1* and p.M37I and p.W239C in *ND2*) was not found to be statistically significant (p value \>0.05) in our study population.

Recent studies have shown that G4580A (p.M37I) in *ND2* and G10398A (p.A114T) in *ND3* are associated with an increase in production of ROS due to altered complex I function \[[@r33]-[@r35]\]. G4580A (p.M37I) was present in 1 patient and G10398A (p.A114T) in 16 patients in our study. The frequency of G10398A (p.A114T) alteration was found to be statistically significant (p value \<0.001) in our study population. Twenty patients (57.14%) had changes associated with elevated ROS production. It has been reported that alterations in mitochondrial complex I causes cytochrome c oxidase deficiency and OS \[[@r36]\]. Pathogenic mutations in ND genes have been reported in POAG, PACG, and PEG \[[@r11],[@r13],[@r14]\].

In this study we found mtDNA sequence changes which were different from other types of glaucoma. When compared between cases and controls, frequency of non-synonymous sequence variations in *ND2* and *ND3* were found to be statistically significant (p value \<0.05; [Table 4](#t4){ref-type="table"}). Point mutations in *ND1*, *ND4*, and *ND6* have been reported in association with LHON \[[@r37],[@r38]\]. Moreover, mutations in complex I genes are also associated with Leigh syndrome, mitochondrial encephalomyopathy, lactic acidosis stroke-like episodes (MELAS), and infertility \[[@r15],[@r39]-[@r41]\].

###### With p-value and Relative risk at 95% confidence interval by using Pearson χ^2^/Fisher's exact test for non-synonymous sequence variations in different mitochondrial genes in PCG and controls.

  **Gene name**   **Cases (n=35)**   **Controls (n=40)**   **p-value**   **Relative risk at 95% confidence interval**
  --------------- ------------------ --------------------- ------------- ----------------------------------------------
  *ND1*           6 (17.14%)         2 (5.0%)              0.136         1.73 (1.07--2.81)
  *ND2*           10 (28.57%)        2 (5.0%)              0.005         2.10 (1.41--3.12)
  *ND3*           17 (48.60%)        0 (0%)                \<0.001       3.22 (2.19--4.72)
  *ND4*           0 (0%)             0 (0%)                ----          -----
  *ND4L*          0 (0%)             2 (5.0%)              0.495         1.92 (1.54--2.39)
  *ND5*           21 (60.00%)        4 (10.0%)             \<0.001       3.00 (1.86--4.83)
  *CO1*           4 (11.42%)         0 (0%)                0.043         2.29 (1.75--2.98)
  *CO2*           5 (14.30%)         0 (0%)                0.019         2.33 (1.78--3.05)
  *CO3*           1 (2.90%)          0 (0%)                0.467         2.17 (1.70--2.78)
  *CYB*           4 (11.42%)         8 (20.00%)            0.360         0.57 (0.18--1.73)
  *ATPase6*       18 (51.42%)        7 (17.50%)            0.002         2.12 (1.34--3.34)
  *ATPase8*       1 (2.85%)          1 (2.5)               1.00          1.07 (0.26--4.40)
  Others          8 (22.85%)         0 (0%)                0.001         2.48 (1.85--3.32)

Abbrevations: *ND1*- NADH dehydrogenase subunit 1; *ND2*- NADH dehydrogenase subunit 2; *ND3*- NADH dehydrogenase subunit 3; *ND4*- NADH dehydrogenase subunit 4; *ND4L*- NADH dehydrogenase subunit 4L; *ND5*- NADH dehydrogenase subunit 5; *CO1*- cytochrome c oxidase I; *CO2*- cytochrome c oxidase II; *CO3*- cytochrome c oxidase III; *ATPase6*- ATP synthase subunit a (F-ATPase protein 6); *ATPase8*- ATP synthase protein 8; *CYB*- cytochrome B; tRNA- transfer ribo nucleic acid; rRNA- ribosomal ribonucleic acid.

Cytochrome c oxidase (COX or complex IV), the terminal enzyme of the respiratory chain (RC) catalyzes the reduction of molecular oxygen by reduced cytochrome c. This complex is composed of 13 subunits \[[@r42]\]. Twenty six variations (19.69%) identified in this study were present in complex IV of which six were non-synonymous. Frequency of non-synonymous sequence variations in *COI* and *COII* in PCG cases were found to be statistically significant (p value \<0.05; [Table 4](#t4){ref-type="table"}). Human diseases associated with COX mutations include POAG, PACG, PEG, and Leigh syndrome \[[@r11],[@r13],[@r14],[@r43]\]. The frequency of non-synonymous sequence variations in *CYB* was not found to be statistically significant (p value \>0.05; [Table 4](#t4){ref-type="table"}).

In the current study, 15.15% mtDNA variations (20/132) were observed in complex V (*ATPase6* and *ATPase8*). Mutations in *ATPase6* have been reported in POAG, PACG, PEG, neuropathy, ataxia, retinitis pigmentosa (NARP), and mitochondrial DNA-associated Leigh Syndrome (MILS) patients \[[@r11],[@r13],[@r14],[@r44],[@r45]\]. Mitochondrial variations in *ATPase6* and *ATPase8* have been reported in spinocerebellar ataxias \[[@r46]\].

The A12308G variation in tRNA leu gene is also associated with increased ROS production \[[@r34]\] and this variation was detected in three patients in this study. However, the frequency of the A12308G variation and non-synonymous variations in *ATPase8* was not found to be statistically significant (p value \>0.05) while that of non-synonymous variations in *ATPase6* and others (16s RNA, tRNA), as shown in [Table 4](#t4){ref-type="table"}, were statistically significant (p value \<0.05).

Non-synonymous mitochondrial variations adversely affect oxidative phosphorylation resulting in decreased mitochondrial respiration and increased free radical (FR) production \[[@r47]\]. Thus, we hypothesize that mtDNA variations with resultant lower ATP levels may impair growth, development, and differentiation of TM and result in trabecular-dysgenesis ([Figure 3](#f3){ref-type="fig"}); a characteristic feature of PCG. Trabecular-dysgenesis leads to impairment in aqueous drainage hence causes elevation in IOP. ROS levels may increase to supraphysiological levels in TM endothelial cells and due to low ATP levels these cells are unable to eliminate the reactive oxygen intermediates (ROI). MtDNA mutations are also associated with optic neuropathies like LHON \[[@r38]\], NARP \[[@r48],[@r49]\] or Leigh syndrome \[[@r50]\]. The mechanisms by which mitochondrial abnormalities may place the optic nerve at risk remain uncertain \[[@r51]\].

![Possible role of mitochondrial sequence variations in trabecular-dysgenesis and RGC cell death in primary congenital glaucoma. Abbrevations: RGCs- Retinal ganglion cells; TM- trabecular meshwork; ROS- reactive oxygen species; ATP- adenosine tri phosphate; IOP- intra ocular pressure.](mv-v16-518-f3){#f3}

Distribution of high number of mitochondria in the optic nerve head reflects the high energy requirement of the human optic nerve head. Neurons, because of their high energy requirement, are heavily dependent on mitochondria for survival \[[@r52]\]. Mitochondria not only constitute an energy-generating system, but are also critically involved in calcium signaling and apoptosis. Mitochondrial function is impaired by mutations in mitochondrial and nuclear DNA, chemical insults to components of the electron transport chain, and a lack of substrates such as oxygen. The latter is relevant to tissue hypoxia that is believed to be present in the glaucomatous retina and optic nerve head either primarily or secondary to elevated IOP. Any malfunction of the mitochondrial electron transport chain results in excessive generation of free radicals and low ATP production. In our study we identified 50.00% variations in complex I, 9.02% in complex III, 19.54% in complex IV, and 15.03% in complex V. The presence of primary LHON mutations has been investigated previously in normal tension glaucoma and POAG \[[@r12],[@r53]\] but not in PCG. None of PCG cases had primary LHON mutations (3460G\>A, 11778G\>A, 14484T\>C) in the current study.

It has already been reported that OS leads to oxidative damage to cellular macromolecules such as mitochondrial and nuclear DNA, proteins, and lipids, along with energy depletion and a local dysregulation of calcium homeostasis, resulting in neuronal degeneration \[[@r54]\]. OS is the underlying etiology in several ocular diseases \[[@r11],[@r54]-[@r59]\] and plays an essential role in early retinal ischemic injury \[[@r60]\] and glaucoma pathogenesis \[[@r61],[@r62]\]. Mitochondrial dysfunction leads to RGC death through caspase-dependent and caspase-independent pathways initiated by the loss of mitochondrial membrane potential, release of cell death mediators and OS \[[@r54]\]. Glaucomatous eyes have a significant increase in OS and decreased antioxidant activity \[[@r62]\]. Seppet et al. \[[@r63]\] reported that OS is a critical factor in injury to anterior segment of eye. OS has also been reported to induce human trabecular meshwork degenerative changes that favor increased intraocular pressure \[[@r64]\]. Oxidative DNA damage is significantly increased in the trabecular-meshwork (TM) of glaucomatous patients compared to controls \[[@r11]\]. The pathogenic role of ROS in glaucoma is supported by various experimental findings, including (a) resistance to aqueous humor outflow is increased by hydrogen peroxide by inducing TM degeneration and (b) intraocular-pressure increase and severity of visual loss in glaucoma patients parallel to the amount of oxidative DNA damage affecting TM \[[@r11]\]. Oxidative damage constitutes an important pathogenic step triggering TM degeneration which results in intraocular hypertension. OS thus affects both TM and retinal ganglion cells, and may be involved in the neuronal cell death affecting the optic nerve in glaucoma ([Figure 3](#f3){ref-type="fig"}).

Further evidence of oxidative damage in trabecular meshwork in glaucoma \[[@r57]\] and neural degeneration is that many retinal proteins exhibit oxidative modifications in experimental glaucoma \[[@r65]\], and may lead to important structural and functional alterations. Thus, the structure and function of mitochondria are critical determinants of endothelial cells and neuronal health. Essentially, once the mitochondrial lipid bilayer is compromised after the mitochondrial translocation of Bcl-2--associated X protein (Bax), cell death is inevitable, because of already triggered events.

It has been established that pathogenic mitochondrial mutations can cause mitochondrial dysfunction and enhance OS, which in turn lead to apoptosis in affected tissue and primary culture of human cells that harbor mtDNA mutations \[[@r66]\]. There are several studies which point to mitochondrial dysfunction in glaucoma and RGC death \[[@r66]-[@r68]\]. One hypothesis suggests that progressive optic nerve damage in POAG is the result of optic nerve fiber apoptosis \[[@r67]\]. Mitochondria-induced apoptosis, which may be a mechanism of injury in experimental glaucoma \[[@r67]\] and other optic neuropathies \[[@r66]\], may also be a pathological factor in PCG. Recent study by Abu-Amero et al. \[[@r11]\] reported mitochondrial dysfunction-associated OS as a risk factor for glaucoma. MtDNA alterations result in reduced mitochondrial respiration \[[@r11]\] and OS \[[@r36]\]. Thus reduced ATP levels secondary to mitochondrial damage may impair development and differentiation of TM. Endothelial cells are also damaged due to supraphysiological ROS levels.

These findings suggest that elevation of IOP is related to oxidative degenerative processes affecting the TM specifically endothelial cells. Much evidence indicates that in this region ROS play a fundamental pathogenic role by reducing local antioxidant activities inducing outflow resistance. TM is neural crest in origin \[[@r69],[@r70]\] and developing TM is deficient in antioxidant enzymes and more susceptible to OS induced DNA damage \[[@r71]\]. OS disturbs Ca^2+^ homeostasis and so raised Ca^2+^ levels activate endonucleases which cause nuclear DNA damage \[[@r63]\]. OS, early in development and/or throughout life could precipitate both metabolic and anatomic sequelae that cause trabecular dysgenesis and ultimately optic nerve damage in PCG.

Elevated IOP is a characteristic feature of glaucoma and an important risk factor for optic nerve damage \[[@r72]\]. However, the precise relationship between among elevated IOP, glaucomatous optic nerve (ON) damage, and retinal ganglion cell death are poorly understood. Growing evidence indicates that mitochondrial structural and functional dynamics play an important role in cell and animal physiology. Imbalance in the control of mitochondrial fusion and fission dramatically alters overall mitochondrial morphology \[[@r73]-[@r76]\]. Elevated IOP in glaucoma induces reduction of cytochrome c oxidase (COX) activity, mitochondrial fission, mitochondrial matrix swelling, cristae depletion, triggers release of optic nerve atrophy type-I (OPA1), and induces subsequent apoptotic cell death in differentiated RGC-5 cells \[[@r77],[@r78]\] ([Figure 4](#f4){ref-type="fig"}). Similar findings were also confirmed in a mouse model \[[@r79]\].
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In summary, frequency of mtDNA sequence variations in PCG was significantly higher as compared to controls. Five pathogenic changes (3 in *ND1* and 2 in *ND2*) and 3 other changes (G10398A, A12308G, and G13708A) associated with elevated ROS were present in our patients. Non-synonymous mtDNA alterations may lead to mitochondrial dysfunction which leads to reduced mitochondrial respiration, OS, damage to mtDNA, altered mitochondrial morphology, alterations in mitochondrial fission and fusion, and ultimately cell's demise. OS impairs development and differentiation of trabecular meshwork that favor increased intraocular pressure in PCG and consequently RGC death.

This study describes mtDNA sequence variations in a relatively small number of patients with PCG of north Indian ethnic origin. However, these results should be confirmed in other populations. Knowledge of mtDNA mutations and/or mitochondrial dysfunction in PCG may lead to a better understanding of glaucoma pathophysiology \[[@r80]\]. Novel approaches are now available for studying mitochondrial disease in the eye, and a novel in vitro treatment has already been devised for the metabolic defect of at least one mtDNA mutation in LHON \[[@r81]\]. PCG cases with mtDNA variations and consequent OS may benefit by early diagnosis and prompt management with antioxidant therapy.

Conclusion
----------

A total of 44 novel mtDNA variations were identified in current study. MtDNA variations adversely affect respiratory chain, impair the OXPHOS pathway resulting in low ATP production, and impair growth, development, and differentiation of TM. Mitochondrial DNA variations also lead to increased ROS production, oxidative injury to TM and RGCs. Thus, early diagnosis of mitochondrial DNA variations and prompt antioxidant administration may delay OS induced injury to TM and RGCs and hence improve visual prognosis.
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